Loading…
RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
Saved in:
Published in: | JNCI : Journal of the National Cancer Institute 2022-01, Vol.114 (1), p.165-166 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c444t-410b5d2860f0a526b6101efb3000c886953f748dfd7f14b11f90f897b6d94c223 |
---|---|
cites | |
container_end_page | 166 |
container_issue | 1 |
container_start_page | 165 |
container_title | JNCI : Journal of the National Cancer Institute |
container_volume | 114 |
creator | Klar, Natalie Adams, Sylvia |
description | |
doi_str_mv | 10.1093/jnci/djab152 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8755500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jnci/djab152</oup_id><sourcerecordid>2561926103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-410b5d2860f0a526b6101efb3000c886953f748dfd7f14b11f90f897b6d94c223</originalsourceid><addsrcrecordid>eNp9kc1r3DAQxUVpaDZpbzkXQQ_NoU4kWZKtHgqbJV8QSCnpWci2lJWxJVeS0-a_j5bdhqaHzGUO8-PNezwAjjA6wUiUp71r7WnXqwYz8gYsMOWoIBixt2CBEKmKuq7oPjiIsUd5BKHvwH5JS8FLQRbA_zj_CpddPz8ol-Ay-FElFTW8dmvb2ORDhD7AOzX6P9ZoBy_8MPjf1t3D1VqPPq11UNMjNBn6roMdtfOTmqMa4FnQKia4Uq7V-aiS1S7F92DPqCHqD7t9CH5enN-troqb28vr1fKmaCmlqaAYNawjNUcGKUZ4wzHC2jRljtDWNResNBWtO9NVBtMGYyOQqUXV8E7QlpDyEHzb6k5zM-quzb-DGuSULarwKL2y8uXF2bW89w-yrhhjCGWB451A8L9mHZMcbWz1MCin_RwlYRwLkm2VGf30H9r7ObgcTxJOOOKU8A31ZUu1wccYtHk2g5HcNCk3Tcpdkxn_-G-AZ_hvdRn4vAX8PL0u9QSnUamD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626064263</pqid></control><display><type>article</type><title>RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients</title><source>Oxford Journals Online</source><creator>Klar, Natalie ; Adams, Sylvia</creator><creatorcontrib>Klar, Natalie ; Adams, Sylvia</creatorcontrib><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/djab152</identifier><identifier>PMID: 34396392</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Aromatase ; Breast cancer ; Chemotherapy ; Correspondence</subject><ispartof>JNCI : Journal of the National Cancer Institute, 2022-01, Vol.114 (1), p.165-166</ispartof><rights>The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-410b5d2860f0a526b6101efb3000c886953f748dfd7f14b11f90f897b6d94c223</citedby><orcidid>0000-0002-5972-2265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34396392$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klar, Natalie</creatorcontrib><creatorcontrib>Adams, Sylvia</creatorcontrib><title>RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>J Natl Cancer Inst</addtitle><subject>Aromatase</subject><subject>Breast cancer</subject><subject>Chemotherapy</subject><subject>Correspondence</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc1r3DAQxUVpaDZpbzkXQQ_NoU4kWZKtHgqbJV8QSCnpWci2lJWxJVeS0-a_j5bdhqaHzGUO8-PNezwAjjA6wUiUp71r7WnXqwYz8gYsMOWoIBixt2CBEKmKuq7oPjiIsUd5BKHvwH5JS8FLQRbA_zj_CpddPz8ol-Ay-FElFTW8dmvb2ORDhD7AOzX6P9ZoBy_8MPjf1t3D1VqPPq11UNMjNBn6roMdtfOTmqMa4FnQKia4Uq7V-aiS1S7F92DPqCHqD7t9CH5enN-troqb28vr1fKmaCmlqaAYNawjNUcGKUZ4wzHC2jRljtDWNResNBWtO9NVBtMGYyOQqUXV8E7QlpDyEHzb6k5zM-quzb-DGuSULarwKL2y8uXF2bW89w-yrhhjCGWB451A8L9mHZMcbWz1MCin_RwlYRwLkm2VGf30H9r7ObgcTxJOOOKU8A31ZUu1wccYtHk2g5HcNCk3Tcpdkxn_-G-AZ_hvdRn4vAX8PL0u9QSnUamD</recordid><startdate>20220111</startdate><enddate>20220111</enddate><creator>Klar, Natalie</creator><creator>Adams, Sylvia</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5972-2265</orcidid></search><sort><creationdate>20220111</creationdate><title>RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients</title><author>Klar, Natalie ; Adams, Sylvia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-410b5d2860f0a526b6101efb3000c886953f748dfd7f14b11f90f897b6d94c223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aromatase</topic><topic>Breast cancer</topic><topic>Chemotherapy</topic><topic>Correspondence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klar, Natalie</creatorcontrib><creatorcontrib>Adams, Sylvia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klar, Natalie</au><au>Adams, Sylvia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>J Natl Cancer Inst</addtitle><date>2022-01-11</date><risdate>2022</risdate><volume>114</volume><issue>1</issue><spage>165</spage><epage>166</epage><pages>165-166</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><cop>United States</cop><pub>Oxford University Press</pub><pmid>34396392</pmid><doi>10.1093/jnci/djab152</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-5972-2265</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8874 |
ispartof | JNCI : Journal of the National Cancer Institute, 2022-01, Vol.114 (1), p.165-166 |
issn | 0027-8874 1460-2105 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8755500 |
source | Oxford Journals Online |
subjects | Aromatase Breast cancer Chemotherapy Correspondence |
title | RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T14%3A04%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RE:%20Adjuvant%20Aromatase%20Inhibitors%20or%20Tamoxifen%20Following%20Chemotherapy%20for%20Perimenopausal%20Breast%20Cancer%20Patients&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Klar,%20Natalie&rft.date=2022-01-11&rft.volume=114&rft.issue=1&rft.spage=165&rft.epage=166&rft.pages=165-166&rft.issn=0027-8874&rft.eissn=1460-2105&rft_id=info:doi/10.1093/jnci/djab152&rft_dat=%3Cproquest_pubme%3E2561926103%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c444t-410b5d2860f0a526b6101efb3000c886953f748dfd7f14b11f90f897b6d94c223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2626064263&rft_id=info:pmid/34396392&rft_oup_id=10.1093/jnci/djab152&rfr_iscdi=true |